Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy
Study of the Effects of Cardiac Resynchronization Therapy (CRT) and Left Ventricular Assist Devices (LVAD) Therapy
1 other identifier
observational
6
1 country
1
Brief Summary
Cardiac resynchronization therapy (CRT) or biventricular pacing is a useful treatment for heart failure and those suffering from arrhythmias. The purpose of this research study is to determine the effect left-ventricular pacing has on patients who have a ventricular assist device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2014
CompletedFirst Posted
Study publicly available on registry
March 11, 2014
CompletedStudy Start
First participant enrolled
April 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2017
CompletedFebruary 8, 2017
February 1, 2017
2.7 years
March 4, 2014
February 7, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in echocardiographic parameters
A comparison of the echocardiogram completed at enrollment and at 30 days.
Change in baseline to 30 days
6 minute walk distance
A trained staff member will supervise participants in the completion of a 6 minute walk test. They will be instructed to walk on a level surface, on a clearly marked indoor course. heart rate and oxygen level will be monitored. The total distance completed at the end of 6 minutes will be noted.
Change in baseline to 30 days
Quality of Life
A comparison of the questionnaires completed at enrollment and at 30 days.
Change in baseline to 30 days
Number of Ventricular Tachycardia Episodes
At baseline and again at 30 days CRT device interrogation will be done to count the number of ventricular tachycardia episodes with LV pacing on and off.
Change in baseline to 30 days
Study Arms (1)
LVAD CRT
The following procedures will be performed: limited echocardiogram, an adjustment to the CRT device's programmed settings, follow-up in 30 days to adjust the CRT device's programmed settings. In addition, quality of life questionnaires will be filled out and a 6 minute walk test will be completed.
Interventions
The following procedures will be performed: limited echocardiogram, an adjustment to the CRT device's programmed settings, follow-up in 30 days to adjust the CRT device's programmed settings. In addition, quality of life questionnaires will be filled out and a 6 minute walk test will be completed.
Eligibility Criteria
Adults with ventricular dysfunction, dyssynchrony, functional capacity presence of arrhythmia. LVAD patients undergo 6 minute walk testing and complete a quality of life questionnaire routinely as part of their care on our LVAD clinic. Additionally, periodic echcoardiography is obtained to determine LVAD dynamics and ventrocular dimensions. We will utilize this information for our study, as well as information from their cardiac resynchronization devices, which is part of routine care for patietns with pacemakers and defibrillators.
You may qualify if:
- Presence of LVAD support and CRT device with working LV lead in patients \> 18years of age
- Left ventricular pacing at time of enrollment
You may not qualify if:
- LV lead dysfunction
- Prior AV node ablation
- Presence of total heart block
- Presence of significant bradycardia/lack of underlying rhythm
- Inability to complete 6 minute walk test
- Inability to return to clinic for repeat assessment
- Any LVAD programmed speed change within the prior 30 days
- Any CRT programming changes within the prior 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32610, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mustafa Ahmed, MD
University of Florida
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2014
First Posted
March 11, 2014
Study Start
April 28, 2014
Primary Completion
January 1, 2017
Study Completion
February 2, 2017
Last Updated
February 8, 2017
Record last verified: 2017-02